MedPath

Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia

Not Applicable
Conditions
Neonatal Hyperbilirubinemia
Oxidative Stress
Phototherapy Complication
Interventions
Procedure: phototherapy
Registration Number
NCT03074292
Lead Sponsor
Rania Ali El-Farrash
Brief Summary

The aim of the present study is to test a hypothesis assuming that phototherapy might have an effect on oxidant/antioxidant status in term and late-preterm neonates with unconjugated hyperbilirubinemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Term and late-preterm neonates (≥35weeks) according to the guidelines of the American Academy of Pediatrics (2004) which stated that gestational ages of newborns were determined according to the first day of the mother's last menstrual period (by the mother's statement) and were additionally confirmed by the Ballard scoring system (Ballard et al., 1991) and antenatal ultrasonographic estimation or obstetric records if present.
  • Clinical significant indirect hyperbilirubinemia requiring phototherapy in the first week of life.
  • Normal blood counts and peripheral blood smears
  • Normal reticulocytic count.
  • Breast fed newborn.
Exclusion Criteria
  • Those in whom the total serum bilirubin (TSB) level rose by more than 5 mg/dl per day or was higher than 20 mg/dl within the first 24 hours after birth were excluded from the study.
  • Infant of diabetic mothers.
  • Maternal eclampsia-preeclampsia.
  • Birth asphyxia
  • Sepsis
  • congenital anomalies.
  • Direct Coombs'test positive
  • Pathological causes of hyperbilirubinemia.
  • Enclosed hemorrhage.
  • Hemolytic type of hyperbilirubinemia due to blood group or Rh incompatibility.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
conventional phototherapyphototherapyneonates with unconjugated hyperbilirubinemia exposed to conventional phototherapy
extensive phototherapyphototherapyneonates with unconjugated hyperbilirubinemia exposed to extensive phototherapy
LED phototherapyphototherapyneonates with unconjugated hyperbilirubinemia exposed to LED phototherapy
Primary Outcome Measures
NameTimeMethod
Effect of types of phototherapy on change in malonaldehyde (MDA)2 days

This will be determined by:

1. Measure MDA (nmol/L) before and after phototherapy

2. Compare results of MDA (nmol/L) before and after phototherapy.

Effect of types of phototherapy on change in total antioxidant capacity (TAC)2 days

This will be determined by:

1. Measure TAC (mmol/L) before and after phototherapy

2. Compare results of TAC (mmol/L) before and after phototherapy.

Effect of types of phototherapy on change in nitric oxide (NO)2 days

This will be determined by:

1. Measure NO (umol/L) before and after phototherapy

2. Compare results of NO (umol/L) before and after phototherapy.

Secondary Outcome Measures
NameTimeMethod
Effect of types of phototherapy on change in serum iron (Fe)2 days

This will be determined by:

1. Measure serum Fe before and after phototherapy

2. Compare results of serum Fe before and after phototherapy.

Effect of types of phototherapy on change in serum calcium (Zn)2 days

This will be determined by:

1. Measure serum Ca before and after phototherapy

2. Compare results of serum Ca before and after phototherapy.

Effect of types of phototherapy on change in serum zinc (Zn)2 days

This will be determined by:

1. Measure serum Zn before and after phototherapy

2. Compare results of serum Zn before and after phototherapy.

Effect of types of phototherapy on change in serum copper (Cu)2 days

This will be determined by:

1. Measure serum Cu before and after phototherapy

2. Compare results of serum Cu before and after phototherapy.

© Copyright 2025. All Rights Reserved by MedPath